InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Morosini Deborah, Directeur Exécutif des Affaires Cliniques. Insider active across 1 company, notably Prelude Therapeutics Inc. In total, 4 filings have been recorded. Activity tracked since 16 November 2021. The latest transaction was disclosed on 15 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
3,016 shares@ US$1.890.0014% mcap1.5% of flowCommon StockSEC:0001209191-21-070352
3,016 shares@ US$1.890.0014% mcap0.8% of flowCommon StockSEC:0001209191-21-070352:0
28,751 shares@ US$12.850.091% mcap49.2% of flowCommon StockSEC:0001209191-21-065616:0
28,751 shares@ US$12.850.091% mcap98.5% of flowCommon StockSEC:0001209191-21-065616
4 of 4 declarations
About Morosini Deborah
Deborah Morosini is the Executive Vice President of Clinical Affairs at Prelude Therapeutics Inc. She oversees the company's clinical initiatives, contributing to innovation and healthcare improvement.
